Pascal Duijf

Associate Professor @UniversitySA 🇦🇺 Translational Cancer Researcher; almost exclusively on

[Pascal Duijf @DuijfLab]

Our latest review article is now available online: ‘The RB protein: More than a sentry of cell cycle entry’. https://t.co/B8hK5NanPU @FarzanehForouz @dray_lab @CCB_Research @UniversitySA

[Jonne Raaijmakers @JonneRaaij]

Excited to share our latest publication in Cell Reports where we reveal the critical role of SRBD1 in mitotic chromosome segregation.
Read more here: https://t.co/zmATM6xaVE
A big thanks to all our wonderful collaborators - This wouldn't have been possible without you!

[Pascal Duijf @DuijfLab]

@aventura71 Amazing work! Congrats to all. 🎉

[Andrea Ventura @aventura71]

1/ 🚨New paper on ecDNAs from our lab!

We reveal a strategy to engineer extrachromosomal DNA (ecDNA) amplifications in cells & mice. Let's dive in!
🧵👇
https://t.co/ct2s4Rhcty

[Daniele Fachinetti @FachinettiLab]

Check it out the preview of our mechano aneuploidy response paper that will be released early January. A great sneak peek from @ELogarinho team https://t.co/Ahg3L40il0

[Philip Gregory @dr_phil_gregory]

I am recruiting postdocs with experience in cancer cell biology and advanced molecular biology. If you are passionate about gene regulation, RNA splicing, and using CRISPR tools to understand how these processes impact cancer progression contact me for more info. @CCB_Research

[Sarah Boyle 👩🏻‍🔬🎀 @DrSarahBoyle]

This manuscript is now published in the @CytoskelJournal Special Issue: Myosin and Myosin-Dependent Cell Processes. Volume 81, Issue 12 https://t.co/SxeTRlwRce

[Paul DW Kirk @pauldwkirk]

New R package from @jackierao_ @MRC_BSU implementing variational Bayesian finite mixture models to cluster categorical data, with variable selection and semi-supervised outcome guiding if desired. https://t.co/ceb3Y0fllx

[Sharad Kumar @molregulation]

Nice to see this paper from the Gabrielli lab finally out:

https://t.co/g3MBFTWKSP

[Gökhan Cildir @cildir_gokhan]

Excited to share my latest research in immunodeficiencies! We’ve uncovered the impact of IKKα kinase deficiency in humans for the first time. Huge thanks to all co-authors for their contributions. @CCB_Research @UniversitySA @unisaresearch https://t.co/HNqnZbrMH0

[Yoon Lim @YoonLim10]

Please repost!
PhD scholarship @molregulation !
Interested in discovery research in the cell biology of extracellular vesicles (EVs)? We have an exciting @arc_gov_au-funded project for a PhD student.
@CCB_Research @unisaresearch @ANZSEVresearch @ANZSCDB

[Pascal Duijf @DuijfLab]

We are looking for a postdoctoral fellow! Apply by Sunday 3 November, if you are interested 🙂 https://t.co/71Ag3wpXBH

[luke isbel @LukeIsbel]

Honoured to receive the Viertel Senior Medical Research Fellowship for my work on epigenetic regulation in cancer at @SAiGENCI @ACEpigenetics @UniofAdelaide! Thank you to the Viertel Foundation and my incredible mentors! https://t.co/YBtP9N3739

[McManusLab @KirkMcManusLab]

Congrats to @rubicamposg and team for their article in @BrJCancer showing that EMI1 regulates chromosome stability and discussing how its abnormal expression impacts #cancer development: https://t.co/xzonFtL6BD
Support from: @CRSNG_NSERC @SRC_CRS @QuIPS_Platform @CancerCareMBFdn

[Ben-David Lab @BenDavidLab]

Our Review on “Aneuploidy as a driver of human cancer” is out in Nature Genetics. Check it out! 🎉

The Ben-David lab wishes everyone Shana Tova — may the new year be much better than the ending one, bringing peace and stability to all! 🙏

https://t.co/OhfhqvpaMh

[Fatwa Adikusuma PhD @Fatwa_Adikusuma]

Excited to share that our study on generating a humanized DMD mouse model using CRISPR has been published! This model will be instrumental in advancing research for potential therapies. Huge thanks to the team for their dedication! #CRISPR #DMD #Research

https://t.co/gAKcOgGgvh

[Aideen McInerney-Leo she/her @Amcinerneyleo]

Excited to share our review on #genomic testing for children, adolescents & young adults with #Cancer

- 16-18% germline variant - 40% de novo
- CNVs ++ than in adults
- 18-69% have variant with a matched therapy - 1/3 receive it.

@CancerAustralia

https://t.co/lHQJlchd36

[Pascal Duijf @DuijfLab]

@aventura71 Congrats to Gaspare!🎉

[Ping Mu 🇺🇦 @PingMu_PhD]

Super excited to share that we’ve moved to Yale University’s Department of Urology to continue our prostate cancer research. Already loving the Yale community and looking forward to some awesome collaborations ahead. @Yale_Urology @YaleMed @YaleCancer @Yale

[Lisa Ebert @lisamebert]

We are recruiting! Come join us in Adelaide to work on cutting-edge translational research and contribute to developing CAR-T cell therapies for brain tumours. Two post-doc positions available, closing soon, details at https://t.co/rIke1TXUds